LSE - Small Logo
LSE - Small Logo

Jane Dickson

February 2nd, 2016

3D printing of drugs: “the possibilities seem endless”

0 comments

Estimated reading time: 5 minutes

Jane Dickson

February 2nd, 2016

3D printing of drugs: “the possibilities seem endless”

0 comments

Estimated reading time: 5 minutes

The possibilities do seem endless, but the Guardian asks whether the 3D printing of medications is safe. They speculate how the pharmacies might change if drugs were printed in local pharmacies, to exact and personalized formulations. The FDA has already given the go-ahead for Spritam levetiracetam (a drug used to control epilepsy) and the hope is to follow with other medications and seek approval across the pond in the UK.

As William Gibson said “the future is here now – it’s just unevenly distributed”.

About the author

Jane Dickson

I am an anthropologist on the D3 Delivering Digital Drugs Project based at LSE. I completed my PhD in the material culture of sustainability and green roofs. In my spare time I craft with glass, explore molecular gastronomy and love Sci-Fi.

Posted In: Personalised medicine | Research

Leave a Reply

Your email address will not be published. Required fields are marked *

Meta